• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格陵兰因纽特人的DNA多态性与血管疾病风险因素的血浆水平——这与因纽特人心血管疾病的低风险有关吗?

DNA-polymorphisms and plasma levels of vascular disease risk factors in Greenland Inuit--is there a relation with the low risk of cardiovascular disease in the Inuit?

作者信息

de Maat M P, Bladbjerg E M, Johansen L G, de Knijff P, Gram J, Kluft C, Jespersen J

机构信息

Department of Thrombosis Research, University of Southern Denmark, Ribe County Hospital, Esbjerg.

出版信息

Thromb Haemost. 1999 Apr;81(4):547-52.

PMID:10235437
Abstract

Greenland Inuit are a population with a low risk of cardiovascular disease. Recently, we stated that frequencies of potentially high risk alleles of the apolipoproteins, fibrinogen, factor V, glycoprotein IIIa and factor VII (FVII) genes have different allele frequencies in the Inuit when compared with Caucasian populations. We have extended this study and evaluated whether or not this was also true for the genetic polymorphisms of tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor-1 (PAI-1), angiotensin-converting enzyme (ACE) and angiotensinogen in a group of 133 Greenland Inuit, aged 30-34 gamma. In addition, we compared the plasma levels of these factors and those of C-reactive protein (CRP) and D-Dimer in Inuit and in Danes, comparable for age and gender. Frequencies (f) were assessed of the alleles that are known as the potential high risk alleles in Caucasians. In the Inuit, the f(insertion allele) of the t-PA intron8ins311 polymorphism was 0.37 (CI 0.32-0.43), the f(4G allele) of the PAI-1 promoter polymorphism was 0.88 (CI 0.83-0.91), the f(deletion allele) of the ACE intron16ins287 polymorphism was 0.40 (CI 0.33-0.47) and the f(M-allele) of the angiotensinogen M/T353 polymorphism was 0.30(CI 0.25-0.38). As for fibrinogen and FVII polymorphisms, these frequencies are all significantly different from what is reported for Caucasian populations. In the Inuit, plasma levels of fibrinogen and D-Dimer were higher than in the Danes, the PAI-1 levels were lower and FVII, t-PA and CRP levels were comparable. The observed allele frequencies of the polymorphisms of t-PA, fibrinogen, FVII, ACE, angiotensinogen and the plasma levels of PAI-1 and D-Dimer were in accordance with the low CVD risk in the Inuit, considering the observed associations between these measures and CVD risk in Caucasian populations, but for other measures this was not the case (allele frequencies of the PAI-1 polymorphism, and plasma levels of fibrinogen, FVII and t-PA). In conclusion there are clear differences in genetic background and plasma levels of risk factors in Greenland Inuit compared with Caucasian populations, and these differences were sometimes, but not always, in accordance with the observed low cardiovascular disease risk of the Inuit population.

摘要

格陵兰因纽特人患心血管疾病的风险较低。最近,我们指出,与白种人群相比,载脂蛋白、纤维蛋白原、凝血因子V、糖蛋白IIIa和凝血因子VII(FVII)基因潜在高风险等位基因的频率在因纽特人中有所不同。我们扩展了这项研究,评估了组织型纤溶酶原激活剂(t-PA)、纤溶酶原激活剂抑制剂-1(PAI-1)、血管紧张素转换酶(ACE)和血管紧张素原的基因多态性在133名年龄在30 - 34岁的格陵兰因纽特人中是否也是如此。此外,我们比较了因纽特人和丹麦人(年龄和性别匹配)这些因子以及C反应蛋白(CRP)和D-二聚体的血浆水平。评估了白种人中已知的潜在高风险等位基因的频率。在因纽特人中,t-PA内含子8插入311多态性的f(插入等位基因)为0.37(95%置信区间0.32 - 0.43),PAI-1启动子多态性的f(4G等位基因)为0.88(95%置信区间0.83 - 0.91),ACE内含子16插入287多态性的f(缺失等位基因)为0.40(95%置信区间0.33 - 0.47),血管紧张素原M/T353多态性的f(M等位基因)为0.30(95%置信区间0.25 - 0.38)。至于纤维蛋白原和FVII多态性,这些频率与白种人群的报道均有显著差异。在因纽特人中,纤维蛋白原和D-二聚体的血浆水平高于丹麦人,PAI-1水平较低,FVII、t-PA和CRP水平相当。考虑到在白种人群中观察到的这些指标与心血管疾病风险之间的关联,t-PA、纤维蛋白原、FVII、ACE、血管紧张素原多态性的观察等位基因频率以及PAI-1和D-二聚体的血浆水平与因纽特人低心血管疾病风险一致,但对于其他指标并非如此(PAI-1多态性的等位基因频率以及纤维蛋白原、FVII和t-PA的血浆水平)。总之,与白种人群相比,格陵兰因纽特人的遗传背景和风险因子血浆水平存在明显差异,这些差异有时但并非总是与因纽特人群中观察到的低心血管疾病风险一致。

相似文献

1
DNA-polymorphisms and plasma levels of vascular disease risk factors in Greenland Inuit--is there a relation with the low risk of cardiovascular disease in the Inuit?格陵兰因纽特人的DNA多态性与血管疾病风险因素的血浆水平——这与因纽特人心血管疾病的低风险有关吗?
Thromb Haemost. 1999 Apr;81(4):547-52.
2
Gender-related association between beta-fibrinogen genotype and plasma fibrinogen levels and linkage disequilibrium at the fibrinogen locus in Greenland Inuit.格陵兰因纽特人中β-纤维蛋白原基因型与血浆纤维蛋白原水平之间的性别相关关联以及纤维蛋白原基因座的连锁不平衡
Arterioscler Thromb Vasc Biol. 1995 Jul;15(7):856-60. doi: 10.1161/01.atv.15.7.856.
3
Longevity is independent of common variations in genes associated with cardiovascular risk.长寿与心血管疾病风险相关基因的常见变异无关。
Thromb Haemost. 1999 Sep;82(3):1100-5.
4
[Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].原发性高血压合并血脂异常患者纤溶酶原激活物抑制剂-1(PAI-1)4G/5G与血管紧张素转换酶(ACE)I/D基因多态性及纤溶活性研究
Pol Arch Med Wewn. 2005 Jan;113(1):7-20.
5
Factor VII polymorphisms in populations with different risks of cardiovascular disease.不同心血管疾病风险人群中的凝血因子VII基因多态性。
Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):1918-23. doi: 10.1161/01.atv.17.10.1918.
6
Association of beta-fibrinogen and factor VII polymorphism with plasma fibrinogen and factor VII levels, and no association of PAI-1 polymorphism with plasma PAI-1 levels in hemodialysis patients.血液透析患者中β-纤维蛋白原和凝血因子VII多态性与血浆纤维蛋白原和凝血因子VII水平的相关性,以及纤溶酶原激活物抑制剂-1多态性与血浆纤溶酶原激活物抑制剂-1水平无相关性。
Clin Nephrol. 2002 Jul;58(1):25-32. doi: 10.5414/cnp58025.
7
[The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].[血管紧张素I转换酶(ACE)基因的I/D多态性及纤溶酶原激活物抑制剂(PAI-1)基因启动子的4G/5G多态性对原发性高血压合并血脂异常患者止血系统的影响]
Ann Acad Med Stetin. 2005;51(1):95-105.
8
Polymorphisms of coagulation/fibrinolysis genes: gene environment interactions and vascular risk.凝血/纤维蛋白溶解基因多态性:基因-环境相互作用与血管风险。
Prostaglandins Leukot Essent Fatty Acids. 1997 Oct;57(4-5):473-7. doi: 10.1016/s0952-3278(97)90431-2.
9
Lifestyle modifies obesity-associated risk of cardiovascular disease in a genetically homogeneous population.在基因同质的人群中,生活方式会改变与肥胖相关的心血管疾病风险。
Am J Clin Nutr. 2006 Jul;84(1):29-36. doi: 10.1093/ajcn/84.1.29.
10
Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis.ACE I/D多态性对血液透析患者血浆纤溶酶原激活物抑制剂1、D-二聚体、超敏C反应蛋白及转化生长因子β1水平的影响
PLoS One. 2016 Mar 29;11(3):e0150613. doi: 10.1371/journal.pone.0150613. eCollection 2016.

引用本文的文献

1
Linkage study of fibrinogen levels: the Strong Heart Family Study.纤维蛋白原水平的连锁研究:强心家族研究
BMC Med Genet. 2008 Aug 12;9:77. doi: 10.1186/1471-2350-9-77.
2
Xenoandrogenic activity in serum differs across European and Inuit populations.欧洲和因纽特人群血清中的异种雄激素活性存在差异。
Environ Health Perspect. 2007 Dec;115 Suppl 1(Suppl 1):21-7. doi: 10.1289/ehp.9353.
3
Dioxin-like activities in serum across European and Inuit populations.欧洲和因纽特人群血清中的二噁英样活性。
Environ Health. 2006 May 25;5:14. doi: 10.1186/1476-069X-5-14.
4
Assessment of subclinical atherosclerosis and cardiovascular risk.亚临床动脉粥样硬化和心血管风险评估。
Clin Cardiol. 2001 Oct;24(10):642-50. doi: 10.1002/clc.4960241003.